Prospective comparison study between 19-gauge needle with .025-inch guidewire and 22-gauge needle with novel .018-inch guidewire during EUS-guided transhepatic biliary drainage (with video) - 14/07/22
Abstract |
Background and Aims |
If the diameter of the intrahepatic bile duct is much less dilated, bile duct puncture with a 19-gauge needle can be challenging during EUS-guided biliary drainage (EUS-BD). These characteristics can decrease the difficulty of bile duct puncture, but use of a 22-gauge needle is less feasible because of poor visibility, maneuverability, and stiffness of the conventional .018-inch guidewire. A novel, improved .018-inch guidewire has recently become available. We conducted a prospective study to evaluate the technical feasibility and safety of EUS-BD in patients with insufficient bile duct dilatation using a 22-gauge needle and the new .018-inch guidewire.
Methods |
A 22-gauge needle was used as the puncture needle for intrahepatic bile ducts of diameters <1.5 mm, and a 19-gauge needle was selected for diameters ≥1.5 mm. As the primary endpoint of the study, the technical success rate of EUS-BD using a 22-gauge needle with the novel .018-inch guidewire was evaluated in patients with insufficient dilation of the intrahepatic bile duct.
Results |
Forty-one patients who required EUS-BD were enrolled (22-gauge needle group, n = 18; 19-gauge needle group, n = 23). Technical success was obtained in all patients in the 19-gauge needle group. In the 22-gauge needle group, technical failure occurred in 2 patients because of nonidentification of the intrahepatic bile duct on EUS (technical success rate, 88.9%), and puncture of the bile duct itself was not performed in these patients. Mean procedure time was similar between the groups. Adverse events were observed in 16.7% of patients (3/16) in the 22-gauge needle group and in 34.8% of patients (8/23) in the 19-gauge needle group.
Conclusions |
Outcomes of using a 22-gauge needle with a novel .018-inch guidewire were comparable with a 19-gauge needle with a .025-inch guidewire, even in the case of insufficient intrahepatic bile duct dilatation. These results require verification in a prospective, randomized trial comparing 22-gauge and 19-gauge needles with a larger sample size. (Clinical trial registration number: UMIN000044441.)
Le texte complet de cet article est disponible en PDF.Abbreviations : EUS-BD, EUS-HGS
Plan
| DISCLOSURE: All authors disclosed no financial relationships. |
Vol 96 - N° 2
P. 262 - août 2022 Retour au numéro
Article précédent
- Disposable versus reusable gastroscopes: a prospective randomized noninferiority trial
- Xiaoya Luo, Ming Ji, Shutian Zhang, Xin Chen, Ye Zong, Xi Zhang, Haiyi Hu, Xiaowen Hao, Linlin Shao, Can Sun, Haiyun Shi, Junxiong Wang, Bangmao Wang, Peng Li
- Incidence of sedation-related adverse events during ERCP with anesthesia assistance: a multicenter observational study
- Linda C. Cummings, Chen Liang, Edward J. Mascha, Leif Saager, Zachary L. Smith, Sekar Bhavani, John J. Vargo, Kenneth C. Cummings
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?